UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 218

Sortiert nach

Pre- and post-transplant quantification of measurable ('minimal') residual disease via multiparameter flow cytometry in adult acute myeloid leukemia

Leukemia, 2016-07, Vol.30 (7), p.1456-1464

2016

Volltextzugriff (PDF)

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center

Leukemia, 2015-02, Vol.29 (2), p.312-320

2015

Volltextzugriff (PDF)

Effect of measurable ('minimal') residual disease (MRD) information on prediction of relapse and survival in adult acute myeloid leukemia

Leukemia, 2016-10, Vol.30 (10), p.2080-2083

2016

Volltextzugriff (PDF)

Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD Anderson

Leukemia, 2014-02, Vol.28 (2), p.289-292

2014

Volltextzugriff (PDF)

Assessing treatment efficacy in the subset of responders in a randomized clinical trial

Annals of oncology, 2017-07, Vol.28 (7), p.1640-1647

2017

Volltextzugriff (PDF)

New drug approvals in acute myeloid leukemia: what's the best end point?

Leukemia, 2016-03, Vol.30 (3), p.521-525

2016

Volltextzugriff (PDF)

Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 study

Leukemia, 2017-12, Vol.31 (12), p.2560-2567

2017

Volltextzugriff (PDF)

Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia

Leukemia, 2015-10, Vol.29 (10), p.2104-2107

2015

Volltextzugriff (PDF)

Prediction of CR following a second course of '7+3' in patients with newly diagnosed acute myeloid leukemia not in CR after a first course

Leukemia, 2016-08, Vol.30 (8), p.1779-1780

2016

Volltextzugriff (PDF)

Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG report

Leukemia, 2013-01, Vol.27 (1), p.238-241

2013

Volltextzugriff (PDF)

Leadership journeys: Impacts of faculty professional development

New directions for community colleges, 2022, Vol.2022 (199), p.119-132

2022

Volltextzugriff (PDF)

Diversity by design: Broadening participation through inclusive teaching

New directions for community colleges, 2022, Vol.2022 (199), p.77-91

2022

Volltextzugriff (PDF)

Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemia

Leukemia, 2014-10, Vol.28 (10), p.1969-1977

2014

Volltextzugriff (PDF)

Development and validation of a model predictive of occult nipple involvement in women undergoing mastectomy

British journal of surgery, 2008-11, Vol.95 (11), p.1356-1361

2008

Volltextzugriff (PDF)

The proportion of CD34+CD38low or neg myeloblasts, but not side population frequency, predicts initial response to induction therapy in patients with newly diagnosed acute myeloid leukemia

Leukemia, 2013-03, Vol.27 (3), p.728-731

2013

Volltextzugriff (PDF)

The proportion of CD34(+)CD38(low or neg) myeloblasts, but not side population frequency, predicts initial response to induction therapy in patients with newly diagnosed acute myeloid leukemia

Leukemia, 2013-03, Vol.27 (3), p.728

2013

Volltextzugriff (PDF)

The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy

Blood cancer journal (New York), 2015-01, Vol.5 (1), p.e276-e276

2015

Volltextzugriff (PDF)

EPV185/#234 Evolving ovarian cancer treatment patterns in the united states from 1982–2018: results from the tempus dataset

International journal of gynecological cancer, 2021-11, Vol.31 (Suppl 4), p.A102-A102

2021

Volltextzugriff (PDF)

371 Relative conditional survival in women with newly-diagnosed ovarian cancer in the United States: results from the tempus dataset, 1982-2018

International journal of gynecological cancer, 2020-11, Vol.30 (Suppl 3), p.A153-A154

2020

Volltextzugriff (PDF)

Role of Adjuvant Regional Nodal Irradiation in Resected Melanoma: A Secondary Analysis of SWOG S1404

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.S82-S83

2022

Volltextzugriff (PDF)

Mean In-field Esophagus Dose Predicts for Esophagitis in Lung Cancer Patients Treated with 3D-CRT and Concurrent Chemotherapy

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S427-S427

2008

Volltextzugriff (PDF)

1073P Quality of life (QOL) endpoints from the phase III intergroup S1404 adjuvant melanoma trial

Annals of oncology, 2021-09, Vol.32, p.S890-S890

2021

Volltextzugriff (PDF)

1069P Granulomatous and sarcoid-like immune adverse events following CTLA4 and PD1 blockade adjuvant therapy of high-risk melanoma: A combined analysis of ECOG-ACRIN E1609 and SWOG S1404 phase III trials

Annals of oncology, 2021-09, Vol.32, p.S887-S888

2021

Volltextzugriff (PDF)

LBA48 Pathologic response and exploratory analyses of neoadjuvant-adjuvant versus adjuvant pembrolizumab (PEM) for resectable stage IIIb-IV melanoma from SWOG S1801

Annals of oncology, 2023-10, Vol.34, p.S1288-S1288

2023

Volltextzugriff (PDF)

LBA6 Neoadjvuant versus adjuvant pembrolizumab for resected stage III-IV melanoma (SWOG S1801)

Annals of oncology, 2022-09, Vol.33, p.S1408

2022

Volltextzugriff (PDF)

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(214)
Mit Volltextzugriff
(200)

Publikationsform

Artikel
(217)
Berichte
(1)

Sprache

Englisch
(218)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(104)
Life Sciences & Biomedicine
(102)
Humans
(88)
Hematology
(73)
Oncology
(73)
Adult
(59)
Female
(52)
Middle Aged
(50)
Male
(48)
Aged
(46)
Acute Myeloid Leukemia
(44)
Aged, 80 And Over
(32)
Leukemia
(32)
Leukemia, Myeloid, Acute - Drug Therapy
(30)
Treatment Outcome
(29)
Leukemia, Myeloid, Acute - Mortality
(25)
Prognosis
(24)
Remission
(23)
Adolescent
(21)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(59)
Leukemia
(30)
Journal Of Clinical Oncology
(16)
Leukemia & Lymphoma
(12)
Haematologica
(11)
Cancer Research
(6)
Annals Of Oncology
(5)
Cancer
(5)
International Journal Of Radiation Oncology, Biology, Physics
(5)
Leukemia & Lymphoma/leukemia And Lymphoma
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Pre- and post-transplant quantification of measurable ('minimal') residual disease via multiparameter flow cytometry in adult acute myeloid leukemia

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center

Effect of measurable ('minimal') residual disease (MRD) information on prediction of relapse and survival in adult acute myeloid leukemia

Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD Anderson

Assessing treatment efficacy in the subset of responders in a randomized clinical trial

New drug approvals in acute myeloid leukemia: what's the best end point?

Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 study

Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia

Prediction of CR following a second course of '7+3' in patients with newly diagnosed acute myeloid leukemia not in CR after a first course

Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG report

Leadership journeys: Impacts of faculty professional development

Diversity by design: Broadening participation through inclusive teaching

Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemia

Development and validation of a model predictive of occult nipple involvement in women undergoing mastectomy

The proportion of CD34+CD38low or neg myeloblasts, but not side population frequency, predicts initial response to induction therapy in patients with newly diagnosed acute myeloid leukemia

The proportion of CD34(+)CD38(low or neg) myeloblasts, but not side population frequency, predicts initial response to induction therapy in patients with newly diagnosed acute myeloid leukemia

The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy

EPV185/#234 Evolving ovarian cancer treatment patterns in the united states from 1982–2018: results from the tempus dataset

371 Relative conditional survival in women with newly-diagnosed ovarian cancer in the United States: results from the tempus dataset, 1982-2018

Role of Adjuvant Regional Nodal Irradiation in Resected Melanoma: A Secondary Analysis of SWOG S1404

Mean In-field Esophagus Dose Predicts for Esophagitis in Lung Cancer Patients Treated with 3D-CRT and Concurrent Chemotherapy

1073P Quality of life (QOL) endpoints from the phase III intergroup S1404 adjuvant melanoma trial

1069P Granulomatous and sarcoid-like immune adverse events following CTLA4 and PD1 blockade adjuvant therapy of high-risk melanoma: A combined analysis of ECOG-ACRIN E1609 and SWOG S1404 phase III trials

LBA48 Pathologic response and exploratory analyses of neoadjuvant-adjuvant versus adjuvant pembrolizumab (PEM) for resectable stage IIIb-IV melanoma from SWOG S1801

LBA6 Neoadjvuant versus adjuvant pembrolizumab for resected stage III-IV melanoma (SWOG S1801)

Suchergebnisse filtern